成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 635713-68-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 635713-68-7
Chemical Structure| 635713-68-7
Structure of 635713-68-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 635713-68-7 ]

Related Doc. of [ 635713-68-7 ]

Alternatived Products of [ 635713-68-7 ]
Product Citations

Product Details of [ 635713-68-7 ]

CAS No. :635713-68-7 MDL No. :MFCD11045505
Formula : C12H15N3O Boiling Point : No data available
Linear Structure Formula :- InChI Key :CFLDCJYCZAHJCK-UHFFFAOYSA-N
M.W : 217.27 Pubchem ID :49760350
Synonyms :

Calculated chemistry of [ 635713-68-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.42
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 3.0
Molar Refractivity : 72.55
TPSA : 53.16 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.84
Log Po/w (XLOGP3) : 0.41
Log Po/w (WLOGP) : -0.04
Log Po/w (MLOGP) : 1.41
Log Po/w (SILICOS-IT) : 1.39
Consensus Log Po/w : 1.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.72
Solubility : 4.11 mg/ml ; 0.0189 mol/l
Class : Very soluble
Log S (Ali) : -1.09
Solubility : 17.5 mg/ml ; 0.0807 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -4.1
Solubility : 0.0174 mg/ml ; 0.00008 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.59

Safety of [ 635713-68-7 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 635713-68-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 635713-68-7 ]

[ 635713-68-7 ] Synthesis Path-Downstream   1~13

  • 1
  • [ 635713-68-7 ]
  • [ 885609-41-6 ]
  • [ 912462-61-4 ]
YieldReaction ConditionsOperation in experiment
79% With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In dichloromethane; for 12h; EXAMPLE 32; (S)-4-chloro-7-(2-oxo-2-(2'-oxo-2',3'-dihydro-1'H-spiro/piperidine-4,4'-quinazoline]-1-yl)ethyl)-9-(2,2,2-trifluoroethyl)-6,7,9,10-tetrahydroazepino[3,4-e]indazol-8(3H)-one; To a solution of (S)-2-(4-chloro-8-oxo-9-(2,2,2-trifluoroethyl)-3,6,7,8,9,10-hexahydroazepino[3,4-e]indazol-7-yl)acetic acid (50 mg, 0.133 mmol) in dichloromethane (25 mL) was added <strong>[635713-68-7]1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-one</strong> (31 mg, 0.14 mmol) followed by 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (47 mg, 0.15 mmol) and triethylamine (1.0 mL). After 12 h, the reaction mixture was washed with aqueous NaHCO3 followed by 1.0 M HCl and dried (Na2SO4). The solvent was removed and the crude product was purified by flash chromatography using 7% MeOH in dichloromethane to give (S)-4-chloro-7-(2-oxo-2-(2'-oxo-2',3'-dihydro-1'H-spiro[piperidine-4,4'-quinazoline]-2'(3'H)-1-yl)ethyl)-9-(2,2,2-trifluoroethyl)-6,7,9,10-tetrahydroazepino[3,4-e]indazol-8(3H)-one (61 mg, 79%) as a white powder. MS (ESI) 575 (M+H); Rf=2.133.
  • 2
  • [ 635713-67-6 ]
  • [ 635713-68-7 ]
YieldReaction ConditionsOperation in experiment
64% With hydrogenchloride; hydrogen;palladium 10% on activated carbon; In methanol; water; under 3102.97 Torr; for 48h; To a solution of [1-BENZYL-2',] [3'-DIHYDRO-2'-OXOSPIRO- [PIPERIDINE-4, 4' (L'H)-] quinazoline (1.00 g) in degassed methanol (50 ml) and 6N hydrochloric acid (2.0 ml) was added 10% palladized charcoal (150 mg). The mixture was shaken on a Parr apparatus under an atmosphere of hydrogen at 60 psi overnight. LC/MS showed incomplete reaction. More 10% palladized charcoal (200 mg) was added, and the mixture was shaken for 2 more days. At that point, all starting material was consumed. The mixture was filtered and the filtrate concentrated to give 531 mg of the desired compound (64%). Mass spec.: 218. 12 (MH) [+.]
64% With hydrogenchloride; hydrogen;palladium 10% on activated carbon; In methanol; water; under 3102.97 Torr; To a solution of 1-benzyl-2',3'-dihydro-2'-oxospiro-[piperidine-4,4'(1'H)-quinazoline (1.00 g) in degassed methanol (50 ml) and 6N hydrochloric acid (2.0 ml) was added 10% palladized charcoal (150 mg). The mixture was shaken on a Parr apparatus under an atmosphere of hydrogen at 60 psi overnight. LC/MS showed incomplete reaction. More 10% palladized charcoal (200 mg) was added, and the mixture was shaken for 2 more days. At that point, all starting material was consumed. The mixture was filtered and the filtrate concentrated to give 531 mg of the desired compound (64%). Mass spec.: 218.12 (MH)+.
  • 3
  • [ 635713-68-7 ]
  • 1',2'-dihydro-2'-oxospiro-4H-3',1-quinazolin'-4,4'-piperidin-1-carboxylic acid-(R)-2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-1-methoxycarbonyl-ethylester [ No CAS ]
  • 4
  • [ 635713-68-7 ]
  • [ 1158918-60-5 ]
  • [ 1158917-88-4 ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; General working method 1 (GMW1) for reacting (6-chloro-pyrimidin-4-yl)-(2,3-dihydro-indol-1-yl)-methanone with amine derivatives:0.41 mmol of an amine derivative were added to 100 mg (0.39 mmol) of (6-chloro-pyrimidin-4-yl)-(2,3-dihydro-indol-1-yl)-methanone and in the case of AA1 [A] 100 muL (0.58 mmol) DIPEA and in the case of AA1 [B] 150 muL (0.87 mmol) DIPEA in 10 mL DMF. The reaction mixture was stirred for 2 h at RT. The reaction mixture was evaporated down using the rotary evaporator and the residue was mixed with 20 mL water and stirred for 30 min at RT. The product precipitated was suction filtered, stirred with diisopropylether and isopropanol, suction filtered again and dried. Amine derivative [amount of amine Example derivative] Analytical Method Structure Yield data Example 2: GWM1 [A] 1'H-spiro[piperi- dine-4,4'-quinazo- lin]-2'(3'H)-one 90 mg (0.41 mmol) 150 mg (88% of theory)ESI-MS: m/z = 441 [M + H]+ Rf: 0.54 eluant A
  • 6
  • [ 635713-68-7 ]
  • [ 1146565-91-4 ]
  • [ 1146565-73-2 ]
YieldReaction ConditionsOperation in experiment
55% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; Example 14-methyl-6-(6-(2'-oxo-2',3'-dihydro-1'H-spiro[piperidin-4,4'-quinazolin]-1-yl)pyrimidine-4-carbonyl)benzo[d]oxazol-2(3H)-one; 144 mg (0.500 mmol) 6-(6-chloropyrimidine-4-carbonyl)-4-methyl-3H-benzoxazol-2-one, 108 mg (0.500 mmol) <strong>[635713-68-7]1'H-spiro[piperidin-4,4'-quinazolin]-2'(3'H)-one</strong> and 0.174 mL (1.00 mmol) DIPEA were combined in 5.0 mL DMF and stirred overnight at RT. The reaction mixture was purified by preparative HPLC, the fractions containing the product were combined and the organic solvent was eliminated i.vac. The aqueous phase was neutralised by the addition of 4N aqueous NaOH solution. The product precipitated as a solid was filtered off, washed with water and dried.Yield: 130 mg (55% of theoretical)ESI-MS: m/z=471 (M+H)+ Rt (HPLC)=2.55 min (Method C)
  • 7
  • [ 635713-68-7 ]
  • [ 1146565-93-6 ]
  • [ 1146565-77-6 ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 48h; Example 33,4-dimethyl-6-(6-(2'-oxo-2',3'-dihydro-1'H-spiro[piperidin-4,4'-quinazolin]-1-yl)pyrimidin-4-carbonyl)benzo[d]oxazol-2(3H)-one; 87.0 mg (0.400 mmol) <strong>[635713-68-7]1'H-spiro[piperidin-4,4'-quinazolin]-2'(3'H)-one</strong>, 122 mg (0.400 mmol) 6-(6-chloropyrimidin-4-carbonyl)-3,4-dimethyl-3H-benzoxazol-2-one and 0.140 mL (0.800 mmol) DIPEA were combined in 3.0 mL DMF and stirred for 48 h at RT. The reaction mixture was diluted with MeOH, the precipitate was suction filtered, washed with diethyl ether and dried.Yield: 184 mg (95% of theoretical)ESI-MS: m/z=485 (M+H)+ Rt (HPLC): 1.14 min (method A)
  • 8
  • [ 635713-68-7 ]
  • [ 1374220-10-6 ]
  • 9
  • [ 635713-68-7 ]
  • [ 773886-68-3 ]
  • 10
  • [ 635713-68-7 ]
  • [ 855776-47-5 ]
  • [ 1374219-97-2 ]
  • 12
  • [ 635713-68-7 ]
  • [ 635713-07-4 ]
  • [ 74124-79-1 ]
  • [ 1384431-99-5 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 635713-68-7 ]

Amides

Chemical Structure| 79098-75-2

[ 79098-75-2 ]

3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one

Similarity: 0.84

Chemical Structure| 41921-63-5

[ 41921-63-5 ]

4,5-Dihydro-1H-benzo[d][1,3]diazepin-2(3H)-one

Similarity: 0.80

Chemical Structure| 3564-73-6

[ 3564-73-6 ]

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.74

Chemical Structure| 66655-67-2

[ 66655-67-2 ]

3,4-Dihydroquinazolin-2(1H)-one

Similarity: 0.70

Chemical Structure| 29331-92-8

[ 29331-92-8 ]

10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.68

Related Parent Nucleus of
[ 635713-68-7 ]

Piperidines

Chemical Structure| 79098-75-2

[ 79098-75-2 ]

3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one

Similarity: 0.84

Chemical Structure| 147769-93-5

[ 147769-93-5 ]

(S)-3-Methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine

Similarity: 0.72

Chemical Structure| 202826-52-6

[ 202826-52-6 ]

1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

Similarity: 0.67

Chemical Structure| 252882-61-4

[ 252882-61-4 ]

Spiro[indoline-3,4'-piperidin]-2-one

Similarity: 0.67

Chemical Structure| 474538-99-3

[ 474538-99-3 ]

1'-Benzylspiro[indoline-3,4'-piperidine]

Similarity: 0.66

Quinazolines

Chemical Structure| 79098-75-2

[ 79098-75-2 ]

3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one

Similarity: 0.84

Chemical Structure| 66655-67-2

[ 66655-67-2 ]

3,4-Dihydroquinazolin-2(1H)-one

Similarity: 0.70

Chemical Structure| 202826-52-6

[ 202826-52-6 ]

1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

Similarity: 0.67

Chemical Structure| 62484-16-6

[ 62484-16-6 ]

6-Methylquinazoline-2,4(1H,3H)-dione

Similarity: 0.66

Chemical Structure| 67449-23-4

[ 67449-23-4 ]

8-Methylquinazoline-2,4(1H,3H)-dione

Similarity: 0.61

Spiroes

Chemical Structure| 202826-52-6

[ 202826-52-6 ]

1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

Similarity: 0.67

Chemical Structure| 252882-61-4

[ 252882-61-4 ]

Spiro[indoline-3,4'-piperidin]-2-one

Similarity: 0.67

Chemical Structure| 69584-91-4

[ 69584-91-4 ]

1'-Methylspiro[indoline-3,4'-piperidine]

Similarity: 0.66

Chemical Structure| 474538-99-3

[ 474538-99-3 ]

1'-Benzylspiro[indoline-3,4'-piperidine]

Similarity: 0.66

Chemical Structure| 356072-46-3

[ 356072-46-3 ]

Spiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.61

; ;